Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069628 · ClinicalTrials.gov registry record · Phase 4
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer
A Phase 4 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT00069628 is a Phase 4 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 200 participants.
The verdict
NCT00069628, a Phase 4 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study will evaluate the safety and effectiveness of a continuous glucose monitor in children with Type 1 diabetes mellitus (T1DM).
Interventions
- DEVICE Continuous Glucose Monitoring System (CGMS)
- DEVICE GlucoWatch® G2™ Biographer (GW2B)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2003-07 |
| Est. Completion | 2004-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00069628
The ClinicalTrials.gov registry entry for NCT00069628 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring System (CGMS) is the first listed.
NCT00069628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00069628 about?
NCT00069628 is a clinical study titled "Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer". This study will evaluate the safety and effectiveness of a continuous glucose monitor in children with Type 1 diabetes mellitus (T1DM).
What is the current status of trial NCT00069628?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2003-07. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00069628?
The interventions under investigation include: Continuous Glucose Monitoring System (CGMS) (DEVICE), GlucoWatch® G2™ Biographer (GW2B) (DEVICE).
Who is sponsoring clinical trial NCT00069628?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.